Form 4 for IOSP INNOSPEC INC.
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0000950170-24-020486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-26 | 2024-02-23 | IOSP | Williams Patrick | Pres, CEO | S - Sale+OE | $124.37 | -9,667 | 181.2K | -5% | -$1.20M |
| D | 2024-02-26 | 2024-02-22 | IOSP | Williams Patrick | Pres, CEO | D - Sale to Iss | $123.96 | -1,318 | 155.0K | -0.8% | -$163.4K |
| D | 2024-02-26 | 2024-02-22 | IOSP | Williams Patrick | Pres, CEO | A - Grant | $0.00 | +29.0K | 184.0K | +19% | $0 |
| D | 2024-02-26 | 2024-02-22 | IOSP | Williams Patrick | Pres, CEO | M - OptEx | $99.85 | +1,318 | 156.3K | +0.9% | +$131.6K |
| D | 2024-02-26 | 2024-02-22 | IOSP | Williams Patrick | Pres, CEO | M - OptEx | $0.00 | -1,318 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | S | D | 11 | $125.15 | 174,334 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-22 | D | D | 1,318 | $123.96 | 155,000 | D | — | — | (F1) Stock Appreciation Right. Vested on February 22, 2024. Vested rights were paid in cash on February 22, 2024 based upon the difference in the closing price of the Company's common stock on the date of grant ($99.85, on February 22, 2021) and on the date of exercise ($123.96, on February 22, 2024). |
| 3 | Common | Common Stock | 2024-02-22 | A | A | 29,001 | $0.00 | 184,001 | D | — | — | (F2) Shares of common stock acquired upon settlement of a performance-based restricted stock unit award granted to the reporting person on February 22, 2021. |
| 4 | Common | Common Stock | 2024-02-23 | S | D | 6,899 | $124.66 | 174,345 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $124.12 to $125.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2024-02-23 | S | D | 2,757 | $123.63 | 181,244 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $123.11 to $124.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2024-02-22 | M | A | 1,318 | $99.85 | 156,318 | D | — | — | |
| 7 | Derivative | Stock Appreciation Right | 2024-02-22 | M | D | 1,318 | $0.00 | 0 | D | $99.85 · 2024-02-22 to 2031-02-22 | 1,318 Common Stock |